Endocrine Society selects Rafael Arrojo e Drigo among its 2027 Laureate Award winners
Rafael Arrojo e Drigo, PhD, of Vanderbilt University, received the Richard E. Weitzman Outstanding Early Career Investigator Award, which recognizes an exceptionally promising young clinical or…
Protein clues in the blood may help children avoid diseases later in life
Study identifies early signs of cardiovascular-kidney-metabolic disease in children that potentially can be reversed with a new class of weight loss drugs used widely by adults.
Researchers identify new therapeutic target for salt-sensitive hypertension
The Vanderbilt Health team, including members of the Kirabo Lab, discovered that a signaling pathway called AP-1 complex links dietary sodium to immune-driven salt-sensitivity of blood pressure,…
Duchenne muscular dystrophy patients are focus of GLP-1 therapy for obesity study
Jaclyn Tamaroff, MD, MSCI, and Jonathan Soslow, MD, MSCI, are co-leading a study evaluating the safety and tolerability of glucagon-like peptide-1 (GLP-1) receptor agonist drugs in patients with…
Registration now open for Diabetes Day 2026
Diabetes Day 2026 will take place at Vanderbilt on Tuesday, Nov. 10. Registration is open now until Nov. 2, 2026. Plenary speakers include Mohammed Ali, MD, Co-Director, Emory Global Diabetes…